Provided is a kit comprising a first pharmaceutical composition comprising a first cannabinoid and optionally a first terpene and/or a first additive; and a second pharmaceutical composition comprising at least one selected from the group consisting of a second cannabinoid, a second terpene, a second additive and combinations thereof, and uses thereof in the treatment of pelvic pain arising from the female reproductive system. Further provided are methods of treatment of pelvic pain arising from a female reproductive system during a menstrual cycle, the method comprising administering during a first fraction of said menstrual cycle a first pharmaceutical composition comprising a first cannabinoid and optionally a first terpene and/or a first additive, and administering during a second fraction of said menstrual cycle a second pharmaceutical composition comprising at least one selected from the group consisting of a second cannabinoid, a second terpene, a second additive and combinations thereof.

The present invention relates to the novel combination of pongamia oil and 4-t-butylcyclohexanol, and to the uses thereof in the fields of cosmetics and dermatology to combat redness.

More specifically, the present invention relates to the cosmetic use of a composition comprising said combination to combat rosacea.

The present invention relates to the novel combination of pongamia oil and 4-t-butylcyclohexanol, and to the uses thereof in the fields of cosmetics and dermatology to combat redness.

More specifically, the present invention relates to the cosmetic use of a composition comprising said combination to combat rosacea.

A medicament for treatment of hypertension based on anion and traditional Chinese medicine, containing active ingredients by percentage weight, which are: 930% of Scutellaria baicalensis, 39% of Radix bupleuri, 312% of Uncaria tomentosa (cat's claw), 39% of Ginseng, 1525% of Cynanchum mooreanum Hemsl., 39% of Cordyceps sinensis (Berk.) Sacc., 1015% of Flastem Milkvetch Seed, 915% of Dermatocarpon miniatum (L.) Mann. [Lichen miniatius L.], 1015% of Millettia dielsiana, 1015% of stem or root of Dalbergia hancei Benth. (Leguminosae), 14% of anion powder and 14% of far-infrared nano powder. Through the use of far infrared nano powder and anion powder with low cost and easily obtainable traditional Chinese medicine, the traditional Chinese medicine is further strengthened with increased efficacy while the far infrared and anion promotes blood circulation and cell repair, which in turn further increases the efficacy and treatment result.

A medicament for treatment of hypertension based on anion and traditional Chinese medicine, containing active ingredients by percentage weight, which are: 930% of Scutellaria baicalensis, 39% of Radix bupleuri, 312% of Uncaria tomentosa (cat's claw), 39% of Ginseng, 1525% of Cynanchum mooreanum Hemsl., 39% of Cordyceps sinensis (Berk.) Sacc., 1015% of Flastem Milkvetch Seed, 915% of Dermatocarpon miniatum (L.) Mann. [Lichen miniatius L.], 1015% of Millettia dielsiana, 1015% of stem or root of Dalbergia hancei Benth. (Leguminosae), 14% of anion powder and 14% of far-infrared nano powder. Through the use of far infrared nano powder and anion powder with low cost and easily obtainable traditional Chinese medicine, the traditional Chinese medicine is further strengthened with increased efficacy while the far infrared and anion promotes blood circulation and cell repair, which in turn further increases the efficacy and treatment result.

A medicament for treatment of hypertension based on anion and traditional Chinese medicine, containing active ingredients by percentage weight, which are: 930% of Scutellaria baicalensis, 39% of Radix bupleuri, 312% of Uncaria tomentosa (cat's claw), 39% of Ginseng, 1525% of Cynanchum mooreanum Hemsl., 39% of Cordyceps sinensis (Berk.) Sacc., 1015% of Flastem Milkvetch Seed, 915% of Dermatocarpon miniatum (L.) Mann. [Lichen miniatius L.], 1015% of Millettia dielsiana, 1015% of stem or root of Dalbergia hancei Benth. (Leguminosae), 14% of anion powder and 14% of far-infrared nano powder. Through the use of far infrared nano powder and anion powder with low cost and easily obtainable traditional Chinese medicine, the traditional Chinese medicine is further strengthened with increased efficacy while the far infrared and anion promotes blood circulation and cell repair, which in turn further increases the efficacy and treatment result.

The present invention provides a phenylpropanoid compound and a preparation method and use thereof. The phenylpropanoid compound has a structural formula shown as formula (I), and the pharmaceutically acceptable salt has a structural formula shown as formula (II), formula (III), formula (IV), or formula (V). The phenylpropanoid compound and the pharmaceutically acceptable salt thereof have an effect on inhibiting a content of an inflammatory cytokine NO and an expression of an inflammatory cytokine TNF-, have an effect on inhibiting a hydroxyl radical (OH), thereby have anti-inflammatory and antioxidant activities, and has a good application prospect in preparing of a medicine for treating an inflammatory disease related to the above factors, such as cervicitis, endometritis, pelvic inflammatory disease, mastitis, sphagitis and/or arthritis. ##STR00001##

The present invention provides a phenylpropanoid compound and a preparation method and use thereof. The phenylpropanoid compound has a structural formula shown as formula (I), and the pharmaceutically acceptable salt has a structural formula shown as formula (II), formula (III), formula (IV), or formula (V). The phenylpropanoid compound and the pharmaceutically acceptable salt thereof have an effect on inhibiting a content of an inflammatory cytokine NO and an expression of an inflammatory cytokine TNF-, have an effect on inhibiting a hydroxyl radical (OH), thereby have anti-inflammatory and antioxidant activities, and has a good application prospect in preparing of a medicine for treating an inflammatory disease related to the above factors, such as cervicitis, endometritis, pelvic inflammatory disease, mastitis, sphagitis and/or arthritis. ##STR00001##

The present invention provides a phenylpropanoid compound and a preparation method and use thereof. The phenylpropanoid compound has a structural formula shown as formula (I), and the pharmaceutically acceptable salt has a structural formula shown as formula (II), formula (III), formula (IV), or formula (V). The phenylpropanoid compound and the pharmaceutically acceptable salt thereof have an effect on inhibiting a content of an inflammatory cytokine NO and an expression of an inflammatory cytokine TNF-, have an effect on inhibiting a hydroxyl radical (OH), thereby have anti-inflammatory and antioxidant activities, and has a good application prospect in preparing of a medicine for treating an inflammatory disease related to the above factors, such as cervicitis, endometritis, pelvic inflammatory disease, mastitis, sphagitis and/or arthritis. ##STR00001##

A cosmetic ingredient, that consists of a solution of at least one extract of karanja oil including pongamol (CAS 484-33-3) and karanjin (CAS 521-88-0) in at least one solvent selected from the group of the diesters having the following formula (I), or mixtures thereof: ##STR00001## In which: n is from 0 to 19; R and R, which may be identical or different, are alkyls derived from an esterification by a linear or branched alcohol of molecular formula C.sub.xH.sub.2x+2O, x being from 1 to 30, from 1 to 20, and from 1 to 10. R is either a hydrogen atom or a C.sub.1-C.sub.3 alkyl group, which also relates to a process of selective precipitation, to a cosmetic formulation and also to the uses thereof.